Jennell advises clients on a wide range of intellectual property and legal matters. She is a strong advocate for clients in and out of court. She takes pride in developing a deep understanding of the disputed technology and the business needs of her clients to achieve favorable outcomes. For instance, in a notable win from the District of Delaware, the Judge found six patents invalid for indefiniteness after the Markman hearing, which saved the client the expense of trial for six of the seven patents-in-suit. With strong briefs and argument, the decision was affirmed at Forest Labs., Inc. v. Teva Pharms. USA, Inc., 716 Fed. Appx. 987 (Fed. Cir. 2017). She represents plaintiffs and defendants in a variety of industries with experience in many forums such as Delaware, Minnesota, New Jersey, Southern District of New York, Connecticut, and the USPTO.

She also helps clients avoid court where possible. For instance, Jennell recently negotiated a favorable resolution with a contract research organization involving a contract dispute, which saved the client the expense of litigation while getting their desired outcome. She also advises clients on complying with federal and state laws directed to the drug, pharmacy, and veterinary industries; life cycle management and design-around options; patent and exclusivity assessments; navigating the drug supply chain; disputes surrounding labeling and marketing claims in the health care space; antitrust. Jennell’s transactional experience involves contract drafting and negotiation, and patent opinions.

Jennell is an adjunct assistant professor in the College of Pharmacy at the University of Minnesota and is a course director for Law in Pharmacy Practice. She currently serves on the Board of Directors for Hennepin Healthcare System, Inc., and Goodwill-Easter Seals Minnesota. Jennell also volunteers for the Metropolitan Council’s CAMP Program (monitoring the water quality for one of Minnesota’s 10,000+ lakes). She is past president and currently serving on the Board of Directors of the American Society for Pharmacy Law.

Her industry experience includes laboratory research in medicinal chemistry and immunology directed labs, research on device with drug for atrial fibrillation, deputy director for the Minnesota Board of Pharmacy, community pharmacist, pharmacy benefit management consultant, and assisting a pharmaceutical economist with antikickback and misbranding statutes, False Claims Act disputes, misappropriation of trade secrets, and antitrust matters.

REPRESENTATIVE CASES